These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
107 related articles for article (PubMed ID: 8957139)
21. Whole-body autoradiographic localization of [3H]phencyclidine and its metabolites in mice. Fand I; McNally WP; Koul O; Yonekura Y; Som P; Brill AB; Deutsch DG Toxicol Appl Pharmacol; 1988 May; 93(3):421-32. PubMed ID: 3368921 [TBL] [Abstract][Full Text] [Related]
22. Anti-phencyclidine monoclonal antibody binding capacity is not the only determinant of effectiveness, disproving the concept that antibody capacity is easily surmounted. Pitas G; Laurenzana EM; Williams DK; Owens SM; Gentry WB Drug Metab Dispos; 2006 Jun; 34(6):906-12. PubMed ID: 16507651 [TBL] [Abstract][Full Text] [Related]
23. Phencyclidine: behavioral and biochemical evidence against the anticholinergic hypothesis. Johnson KM Pharmacol Biochem Behav; 1982 Jul; 17(1):53-7. PubMed ID: 7122667 [TBL] [Abstract][Full Text] [Related]
24. Effects of acute and chronic administrations of phencyclidine on the levels of serotonin and 5-hydroxyindoleacetic acid in discrete brain areas of mouse. Nabeshima T; Hiramatsu M; Furukawa H; Kameyama T Life Sci; 1985 Mar; 36(10):939-46. PubMed ID: 2579308 [TBL] [Abstract][Full Text] [Related]
25. Behavioral effects of chronic phencyclidine administration in rats. Sturgeon RD; Fessler RG; London SF; Meltzer HY Psychopharmacology (Berl); 1982; 76(1):52-6. PubMed ID: 6805009 [TBL] [Abstract][Full Text] [Related]
26. Effect of central injection of phencyclidine on QNB accumulation and motor activity. Boggan W; Middaugh L Eur J Pharmacol; 1989 Jul; 166(2):123-9. PubMed ID: 2792187 [TBL] [Abstract][Full Text] [Related]
27. Interactions between delta9-tetrahydrocannabinol and phencyclidine hydrochloride in rats. Pryor GT; Husain S; Larsen F; McKenzie CE; Carr JD; Braude MC Pharmacol Biochem Behav; 1977 Jan; 6(1):123-36. PubMed ID: 850686 [TBL] [Abstract][Full Text] [Related]
28. Phencyclidine: effects on motor activity and brain biogenic amines in the guinea pig. Johnson KM; Gordon MB; Ziegler MG Pharmacol Biochem Behav; 1978 Oct; 9(4):563-5. PubMed ID: 733843 [TBL] [Abstract][Full Text] [Related]
29. Phencyclidine pharmacokinetics and concentration-response relationships in the pigeon. Owens SM; McMillan DE; Hardwick WC; Wessinger WD Pharmacol Biochem Behav; 1990 Apr; 35(4):797-801. PubMed ID: 2345758 [TBL] [Abstract][Full Text] [Related]
30. Characterization of the effects of the acute and chronic administration of phencyclidine on the release of adrenocorticotropin, corticosterone and prolactin in the rat: evidence for the differential development of tolerance. Pechnick RN; George R; Poland RE; Hiramatsu M; Cho AK J Pharmacol Exp Ther; 1989 Aug; 250(2):534-40. PubMed ID: 2547936 [TBL] [Abstract][Full Text] [Related]
31. Metaphit, an acylating ligand for phencyclidine receptors: characterization of in vivo actions in the rat. Contreras PC; Johnson S; Freedman R; Hoffer B; Olsen K; Rafferty MF; Lessor RA; Rice KC; Jacobson AE; O'Donohue TL J Pharmacol Exp Ther; 1986 Sep; 238(3):1101-7. PubMed ID: 3018219 [TBL] [Abstract][Full Text] [Related]
32. Comparison between intraperitoneal and subcutaneous phencyclidine administration in Sprague-Dawley rats: a locomotor activity and gene induction study. Kalinichev M; Robbins MJ; Hartfield EM; Maycox PR; Moore SH; Savage KM; Austin NE; Jones DN Prog Neuropsychopharmacol Biol Psychiatry; 2008 Feb; 32(2):414-22. PubMed ID: 17945407 [TBL] [Abstract][Full Text] [Related]
33. Effects of repeated treatment of phencyclidine on cognition and gene expression in C57BL/6 mice. Beraki S; Diaz-Heijtz R; Tai F; Ogren SO Int J Neuropsychopharmacol; 2009 Mar; 12(2):243-55. PubMed ID: 18684341 [TBL] [Abstract][Full Text] [Related]
34. Structure-activity relationships of phencyclidine derivatives in rat cerebellum. Pang K; Johnson SW; Maayani S; Freedman R Pharmacol Biochem Behav; 1986 Jan; 24(1):127-34. PubMed ID: 3945656 [TBL] [Abstract][Full Text] [Related]
35. Attenuation of pharmacological effects and increased metabolism of phencyclidine in morphine tolerant mice. Nabeshima T; Sivam SP; Ho IK Eur J Pharmacol; 1984 Sep; 104(3-4):211-21. PubMed ID: 6499921 [TBL] [Abstract][Full Text] [Related]
36. Effects of the mGlu2/3 receptor agonist LY379268 on motor activity in phencyclidine-sensitized rats. Clark M; Johnson BG; Wright RA; Monn JA; Schoepp DD Pharmacol Biochem Behav; 2002 Sep; 73(2):339-46. PubMed ID: 12117588 [TBL] [Abstract][Full Text] [Related]
37. Effect of phencyclidine and two monohydroxy metabolites on 3H QNB binding in vivo in rats. Boggan WO; Stringer AJ; Faught K; Middaugh LD Pharmacol Biochem Behav; 1987 Apr; 26(4):847-9. PubMed ID: 3602041 [TBL] [Abstract][Full Text] [Related]
38. Influence of phencyclidine (PCP) pharmacokinetics on PCP dependence after i.v. and s.c. routes of administration. Wessinger WD; Owens SM NIDA Res Monogr; 1990; 105():431-2. PubMed ID: 1876063 [No Abstract] [Full Text] [Related]
39. Long-term disposition of phencyclidine in mice. Martin BR Drug Metab Dispos; 1982; 10(2):189-93. PubMed ID: 6124408 [TBL] [Abstract][Full Text] [Related]
40. In vivo labeling of phencyclidine (PCP) receptors with 3H-TCP in the mouse brain. Maurice T; Vignon J J Neurosci Res; 1990 Jul; 26(3):377-85. PubMed ID: 2168951 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]